These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25265073)

  • 1. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
    Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
    AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
    Dolan SE; Kanter JR; Grinspoon S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK; Huang M; Prasad GV
    J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of reduced bone mineral density in primary HIV-1-infected men.
    Grijsen ML; Vrouenraets SM; Steingrover R; Lips P; Reiss P; Wit FW; Prins JM
    AIDS; 2010 Sep; 24(14):2233-8. PubMed ID: 20616695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
    Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: HIV Infection Is Associated With Worse Bone Material Properties, Independently of Bone Mineral Density.
    Güerri-Fernández R; Molina D; Villar-García J; Prieto-Alhambra D; Mellibovsky L; Nogués X; González-Mena A; Guelar A; Trenchs-Rodríguez M; Herrera-Fernández S; Horcajada JP; Díez-Pérez A; Knobel H
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):314-8. PubMed ID: 26910501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.
    El-Maouche D; Mehta SH; Sutcliffe C; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS; Brown TT
    J Hepatol; 2011 Oct; 55(4):770-6. PubMed ID: 21338640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
    Mok CC; Wong SN; Ma KM
    Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased bone mineral density in Costello syndrome.
    Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
    Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
    J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo precision of the GE lunar iDXA for the assessment of lumbar spine, total hip, femoral neck, and total body bone mineral density in severely obese patients.
    Carver TE; Christou NV; Court O; Lemke H; Andersen RE
    J Clin Densitom; 2014; 17(1):109-15. PubMed ID: 23896494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of protease inhibitors is associated with bone mineral density loss.
    Kinai E; Nishijima T; Mizushima D; Watanabe K; Aoki T; Honda H; Yazaki H; Genka I; Tanuma J; Teruya K; Tsukada K; Gatanaga H; Kikuchi Y; Oka S
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):553-9. PubMed ID: 24494779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.
    Huang GS; Chu TS; Lou MF; Hwang SL; Yang RS
    BMC Musculoskelet Disord; 2009 Jun; 10():60. PubMed ID: 19497099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.